Insider Transactions in Q3 2025 at Biocryst Pharmaceuticals Inc (BCRX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 13
2025
|
Theresa Heggie Director |
SELL
Open market or private sale
|
Direct |
70,000
-51.72%
|
$560,000
$8.51 P/Share
|
|
Aug 13
2025
|
Theresa Heggie Director |
BUY
Exercise of conversion of derivative security
|
Direct |
70,000
+23.37%
|
$280,000
$4.16 P/Share
|
|
Jul 24
2025
|
Babar Ghias CFO & Head of Corp Development |
BUY
Grant, award, or other acquisition
|
Direct |
147,000
+50.0%
|
-
|